DNDi Template Development Collaboration and License Agreement

• Post author:GHIAA Admin
• Post published:April 19, 2023
• Post category:

Continue ReadingDNDi Template Development Collaboration and License Agreement

Merck – MPP, Molnupiravir License Agreement

• Post author:GHIAA Admin
• Post published:December 15, 2022
• Post category:

Continue ReadingMerck – MPP, Molnupiravir License Agreement

Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement

• Post author:GHIAA Admin
• Post published:September 28, 2022
• Post category:

Continue ReadingGilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement

Shionogi – GARDP, Cefiderocol License Agreement

• Post author:GHIAA Admin
• Post published:July 8, 2022
• Post category:

Continue ReadingShionogi – GARDP, Cefiderocol License Agreement

University of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement

• Post author:GHIAA Admin
• Post published:January 8, 2022
• Post category:

Continue ReadingUniversity of Washington – Medicines Patent Pool, Long-acting Injectable HIV Treatment License Agreement

CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement

• Post author:GHIAA Admin
• Post published:December 14, 2021
• Post category:

Continue ReadingCureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement

Merck – MPP, Molnupiravir License Agreement

• Post author:GHIAA Admin
• Post published:November 22, 2021
• Post category:

Continue ReadingMerck – MPP, Molnupiravir License Agreement